AAPL   382.33 (+0.25%)
MU   49.96 (+0.50%)
GE   6.64 (-3.35%)
TSLA   1,378.98 (+0.96%)
AMD   56.47 (+5.69%)
BAC   22.52 (-2.55%)
BA   173.87 (-3.45%)
AAPL   382.33 (+0.25%)
MU   49.96 (+0.50%)
GE   6.64 (-3.35%)
TSLA   1,378.98 (+0.96%)
AMD   56.47 (+5.69%)
BAC   22.52 (-2.55%)
BA   173.87 (-3.45%)
AAPL   382.33 (+0.25%)
MU   49.96 (+0.50%)
GE   6.64 (-3.35%)
TSLA   1,378.98 (+0.96%)
AMD   56.47 (+5.69%)
BAC   22.52 (-2.55%)
BA   173.87 (-3.45%)
AAPL   382.33 (+0.25%)
MU   49.96 (+0.50%)
GE   6.64 (-3.35%)
TSLA   1,378.98 (+0.96%)
AMD   56.47 (+5.69%)
BAC   22.52 (-2.55%)
BA   173.87 (-3.45%)
Log in

NASDAQ:EXPOExponent Stock Price, Forecast & News

$78.33
-0.65 (-0.82 %)
(As of 07/9/2020 02:14 PM ET)
Add
Compare
Today's Range
$77.01
Now: $78.33
$78.86
50-Day Range
$67.54
MA: $75.98
$82.29
52-Week Range
$57.97
Now: $78.33
$83.54
Volume5,570 shs
Average Volume308,547 shs
Market Capitalization$4.04 billion
P/E Ratio48.96
Dividend Yield0.95%
Beta0.26
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Read More
Exponent logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.89 out of 5 stars


Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryResearch & Consulting Services
Current SymbolNASDAQ:EXPO
CUSIP30214U10
Phone650-326-9400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$417.20 million
Cash Flow$1.68 per share
Book Value$6.76 per share

Profitability

Net Income$82.46 million

Miscellaneous

Employees1,201
Market Cap$4.04 billion
Next Earnings Date7/16/2020 (Estimated)
OptionableOptionable

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Exponent (NASDAQ:EXPO) Frequently Asked Questions

How has Exponent's stock been impacted by COVID-19 (Coronavirus)?

Exponent's stock was trading at $75.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EXPO stock has increased by 3.1% and is now trading at $78.33. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Exponent?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Exponent.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, July 16th 2020. View our earnings forecast for Exponent.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) released its quarterly earnings data on Thursday, April, 30th. The business services provider reported $0.49 EPS for the quarter, beating the consensus estimate of $0.42 by $0.07. The business services provider earned $99.70 million during the quarter, compared to analysts' expectations of $101.21 million. Exponent had a return on equity of 25.03% and a net margin of 20.28%. The firm's quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.42 EPS. View Exponent's earnings history.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Thursday, April 30th. Shareholders of record on Friday, June 12th will be given a dividend of $0.19 per share on Friday, June 26th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Thursday, June 11th. View Exponent's dividend history.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were payable to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

5 analysts have issued 12-month price targets for Exponent's shares. Their forecasts range from $81.00 to $94.00. On average, they anticipate Exponent's share price to reach $86.33 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price. View analysts' price targets for Exponent.

Has Exponent been receiving favorable news coverage?

Press coverage about EXPO stock has trended negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Exponent earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave headlines about the business services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Exponent.

Are investors shorting Exponent?

Exponent saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 858,700 shares, a decline of 15.8% from the May 31st total of 1,020,000 shares. Based on an average daily trading volume, of 342,700 shares, the days-to-cover ratio is presently 2.5 days. Currently, 1.7% of the company's stock are short sold. View Exponent's Current Options Chain.

Who are some of Exponent's key competitors?

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Energy Transfer LP Unit (ET), Pfizer (PFE), Abbott Laboratories (ABT), Ford Motor (F), AT&T (T), Adobe (ADBE), Intel (INTC), Micron Technology (MU) and UnitedHealth Group (UNH).

Who are Exponent's key executives?

Exponent's management team includes the following people:
  • Dr. Paul R. Johnston, Exec. Chairman (Age 65)
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 50)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 53)
  • Dr. Harri K. Kytomaa, Group VP & Principal Engineer (Age 60)
  • Dr. Steven J. Murray, Group VP & Principal Engineer (Age 44)

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.78%), Envestnet Asset Management Inc. (0.41%), State of Alaska Department of Revenue (0.09%), Paragon Advisors LLC (0.02%) and Diversified Trust Co (0.01%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr and Richard Reiss. View institutional ownership trends for Exponent.

Which major investors are buying Exponent stock?

EXPO stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Paragon Advisors LLC, Diversified Trust Co, State of Alaska Department of Revenue, and Riverbridge Partners LLC. View insider buying and selling activity for Exponent.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $78.33.

How big of a company is Exponent?

Exponent has a market capitalization of $4.04 billion and generates $417.20 million in revenue each year. The business services provider earns $82.46 million in net income (profit) each year or $1.53 on an earnings per share basis. Exponent employs 1,201 workers across the globe.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.